Skip to content
Advertisement

In this Feb. 4, 2016 file photo, pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington during the House Committee on Oversight and Reform Committee hearing on a decision by his former company, Turing Pharmaceuticals, to significantly raise the price of the anti-parasitic medication Daraprim. Heated protests at the University of California, Davis brought the cancellation of planned speeches by far-right commentator Milo Yiannopoulos and former pharmaceutical executive Shkreli shortly before the event was to begin. University police put up barricades as protesters shouting "shut it down" grew increasingly rowdy in the hours leading up to the talks on Friday night, Jan. 13, 2017. (AP Photo/Susan Walsh, File)

In this Feb. 4, 2016 file photo, pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington during the House Committee on Oversight and Reform Committee hearing on a decision by his former company, Turing Pharmaceuticals, to significantly raise the price of the anti-parasitic medication Daraprim. Heated protests at the University of California, Davis brought the cancellation of planned speeches by far-right commentator Milo Yiannopoulos and former pharmaceutical executive Shkreli shortly before the event was to begin. University police put up barricades as protesters shouting "shut it down" grew increasingly rowdy in the hours leading up to the talks on Friday night, Jan. 13, 2017. (AP Photo/Susan Walsh, File)

Featured Photo Galleries

01-Army parade.png

Military parade celebrates Army’s 250th

Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.

20250330 Sabatini-Caps-Sabres 001.jpg

Ovi scores goal 890, Caps lose to Sabres 8-5

Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)